HUTCHMED Seeks FDA Approval For ORPATHYS-TAGRISSO In Resistant Lung Cancer

(RTTNews) - HUTCHMED (HCM) announced that AstraZeneca (AZN) has submitted a New Drug Application to the U.S. FDA for ORPATHYS in combination with TAGRISSO for certain patients with advanced non-small cell lung cancer whose disease has progressed after prior EGFR-targeted treatmen